IMCD, NL0010801007

IMCD N.V. stock (NL0010801007): Distributor in AEX index with global reach

14.05.2026 - 20:30:53 | ad-hoc-news.de

IMCD N.V., a specialty chemicals distributor listed on Euronext Amsterdam, maintains a presence in major indices like the AEX. The company focuses on value-added distribution across industries including pharmaceuticals and personal care, with significant exposure to the US market.

IMCD, NL0010801007
IMCD, NL0010801007

IMCD N.V. continues to operate as a key player in specialty chemicals distribution, recently noted in the AEX index composition on Euronext Amsterdam as of recent exchange data. The company, which specializes in distributing chemicals and ingredients, serves diverse sectors with a focus on high-value applications. This positioning underscores its role in global supply chains relevant to US investors tracking European industrials.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: IMCD N.V.
  • Sector/industry: Specialty chemicals distribution
  • Headquarters/country: Netherlands
  • Core markets: Europe, North America, Asia
  • Key revenue drivers: Life science and industrial chemicals
  • Home exchange/listing venue: Euronext Amsterdam (IMCD)
  • Trading currency: EUR

IMCD N.V.: core business model

IMCD N.V. operates as a distributor of specialty chemicals and ingredients, connecting producers with end-users in various industries. The company provides value-added services such as technical support, formulation development, and market intelligence, targeting sectors like pharmaceuticals, food, personal care, and advanced materials. According to its official website, IMCD emphasizes innovation and sustainability in its distribution model, operating in over 60 countries with a network of suppliers and customers.

IMCD N.V. is listed on Euronext Amsterdam under the ticker IMCD and is part of the AEX index, as confirmed by Euronext data. This inclusion highlights its market significance in the Netherlands and broader Europe, with implications for US investors interested in diversified industrials exposure.

Main revenue and product drivers for IMCD N.V.

IMCD N.V. generates revenue primarily from distributing specialty chemicals used in life sciences and industrial applications. Key segments include ingredients for personal care, pharmaceuticals, food & nutrition, and coatings. The company's model relies on exclusive partnerships with suppliers, enabling localized technical expertise. Recent index mentions, such as in ESG-focused ETFs, reflect its alignment with sustainable practices, according to market data from justETF as of 2026.

Geographically, IMCD has substantial US exposure through its North American operations, making it relevant for US investors monitoring supply chain resilience in chemicals.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Official source

For first-hand information on IMCD N.V., visit the company’s official website.

Go to the official website

Why IMCD N.V. matters for US investors

IMCD N.V. offers US investors exposure to the resilient specialty chemicals distribution sector, with North America as a core market. Its role in supplying ingredients for US-based pharmaceuticals and consumer goods ties it to domestic economic trends. Listing on Euronext provides ADR-like access via international brokers.

Conclusion

IMCD N.V. stands as a established distributor in specialty chemicals, with a strong European base and global footprint including the US. Its AEX inclusion and ESG mentions signal market recognition. Investors should monitor sector dynamics and company updates for ongoing developments. The stock remains a point of interest in industrials.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis IMCD Aktien ein!

<b>So schätzen die Börsenprofis  IMCD Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | NL0010801007 | IMCD | boerse | 69336885 | bgmi